Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
Company: Bellvitge Institut for Biomedical Research
Principal Investigator at Bellvitge Institut for Biomedical Research, Barcelona, Spain. His research interests include the characterization of RNA metabolism impaired in human pathologies and the identification of molecular mechanisms that confer sensitivity and resistance to therapies against cancer.